94 related articles for article (PubMed ID: 12052079)
1. Targeting systemically administered proteins to bone by bisphosphonate conjugation.
Uludag H; Yang J
Biotechnol Prog; 2002; 18(3):604-11. PubMed ID: 12052079
[TBL] [Abstract][Full Text] [Related]
2. Bone affinity of a bisphosphonate-conjugated protein in vivo.
Uludag H; Gao T; Wohl GR; Kantoci D; Zernicke RF
Biotechnol Prog; 2000; 16(6):1115-8. PubMed ID: 11101342
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate conjugation to proteins as a means to impart bone affinity.
Uludag H; Kousinioris N; Gao T; Kantoci D
Biotechnol Prog; 2000; 16(2):258-67. PubMed ID: 10753453
[TBL] [Abstract][Full Text] [Related]
4. Imparting mineral affinity to fetuin by bisphosphonate conjugation: a comparison of three bisphosphonate conjugation schemes.
Gittens SA; Bansal G; Kucharski C; Borden M; Uludag H
Mol Pharm; 2005; 2(5):392-406. PubMed ID: 16196492
[TBL] [Abstract][Full Text] [Related]
5. A comparison of mineral affinity of bisphosphonate-protein conjugates constructed with disulfide and thioether linkages.
Wright JE; Gittens SA; Bansal G; Kitov PI; Sindrey D; Kucharski C; Uludağ H
Biomaterials; 2006 Feb; 27(5):769-84. PubMed ID: 16055182
[TBL] [Abstract][Full Text] [Related]
6. A dendritic tetra(bisphosphonic acid) for improved targeting of proteins to bone.
Bansal G; Wright JE; Kucharski C; Uludağ H
Angew Chem Int Ed Engl; 2005 Jun; 44(24):3710-4. PubMed ID: 15880536
[No Abstract] [Full Text] [Related]
7. Improved bone delivery of osteoprotegerin by bisphosphonate conjugation in a rat model of osteoarthritis.
Doschak MR; Kucharski CM; Wright JE; Zernicke RF; Uludağ H
Mol Pharm; 2009; 6(2):634-40. PubMed ID: 19718808
[TBL] [Abstract][Full Text] [Related]
8. Imparting bone mineral affinity to osteogenic proteins through heparin-bisphosphonate conjugates.
Gittens SA; Bagnall K; Matyas JR; Löbenberg R; Uludag H
J Control Release; 2004 Aug; 98(2):255-68. PubMed ID: 15262417
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonate-coated BSA nanoparticles lack bone targeting after systemic administration.
Wang G; Kucharski C; Lin X; Uludağ H
J Drug Target; 2010 Sep; 18(8):611-26. PubMed ID: 20158316
[TBL] [Abstract][Full Text] [Related]
10. A di(bisphosphonic acid) for protein coupling and targeting to bone.
Bansal G; Gittens SA; Uludağ H
J Pharm Sci; 2004 Nov; 93(11):2788-99. PubMed ID: 15368528
[TBL] [Abstract][Full Text] [Related]
11. Imparting mineral affinity to proteins with thiol-labile disulfide linkages.
Bansal G; Wright JE; Zhang S; Zernicke RF; Uludag H
J Biomed Mater Res A; 2005 Sep; 74(4):618-28. PubMed ID: 16037953
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the stability and animal biodistribution of gadolinium (III) benzylamine-derivatized diethylenetriaminepentaacetic acid.
Deal KA; Motekaitis RJ; Martell AE; Welch MJ
J Med Chem; 1996 Aug; 39(16):3096-3106. PubMed ID: 8759630
[TBL] [Abstract][Full Text] [Related]
13. Impact of tether length on bone mineral affinity of protein-bisphosphonate conjugates.
Gittens SA; Kitov PI; Matyas JR; Löbenberg R; Uludağ H
Pharm Res; 2004 Apr; 21(4):608-16. PubMed ID: 15139517
[TBL] [Abstract][Full Text] [Related]
14. Designing proteins for bone targeting.
Gittens SA; Bansal G; Zernicke RF; Uludağ H
Adv Drug Deliv Rev; 2005 May; 57(7):1011-36. PubMed ID: 15876401
[TBL] [Abstract][Full Text] [Related]
15. The interaction of cationic polymers and their bisphosphonate derivatives with hydroxyapatite.
Zhang S; Wright JE; Ozber N; Uludağ H
Macromol Biosci; 2007 May; 7(5):656-70. PubMed ID: 17457941
[TBL] [Abstract][Full Text] [Related]
16. Oral bioavailability and bone-sparing effects of estetrol in an osteoporosis model.
Coelingh Bennink HJ; Heegaard AM; Visser M; Holinka CF; Christiansen C
Climacteric; 2008; 11 Suppl 1():2-14. PubMed ID: 18464016
[TBL] [Abstract][Full Text] [Related]
17. Imparting bone affinity to glycoproteins through the conjugation of bisphosphonates.
Gittens SA; Matyas JR; Zernicke RF; Uludağ H
Pharm Res; 2003 Jul; 20(7):978-87. PubMed ID: 12880282
[TBL] [Abstract][Full Text] [Related]
18. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
[TBL] [Abstract][Full Text] [Related]
19. Osteotropic drug delivery system (ODDS) based on bisphosphonic prodrug. III: Pharmacokinetics and targeting characteristics of osteotropic carboxyfluorescein.
Fujisaki J; Tokunaga Y; Sawamoto T; Takahashi T; Kimura S; Shimojo F; Hata T
J Drug Target; 1996; 4(2):117-23. PubMed ID: 8894972
[TBL] [Abstract][Full Text] [Related]
20. Dried plum reverses bone loss in an osteopenic rat model of osteoporosis.
Deyhim F; Stoecker BJ; Brusewitz GH; Devareddy L; Arjmandi BH
Menopause; 2005; 12(6):755-62. PubMed ID: 16278620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
